The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
J Natl Compr Canc Netw. 2010 Oct;8(10):1148-55. doi: 10.6004/jnccn.2010.0084.
Family history is a key component of breast cancer risk assessment. Family history provides clues as to the likelihood of a hereditary breast cancer syndrome and the need for a cancer genetics referral and can be used in the setting of a breast cancer risk assessment model to estimate a woman's risk. Appropriate breast cancer screening and risk reduction management plans rely on an accurate assessment of a patient's family history. This article reviews the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer Risk Reduction and provides insight into the application of the guidelines in clinical practice.
家族史是乳腺癌风险评估的关键组成部分。家族史提供了遗传性乳腺癌综合征发生可能性的线索,以及癌症遗传学转诊的必要性,并可用于乳腺癌风险评估模型,以估计女性的风险。适当的乳腺癌筛查和降低风险管理计划依赖于对患者家族史的准确评估。本文回顾了 NCCN 肿瘤学临床实践指南(NCCN 指南)中的乳腺癌降低风险,并深入了解了该指南在临床实践中的应用。